← 홈

전체 프로그램

ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 201개
CGTBiologicstaleSichuan UniversityPhase 1

CXCR4 modified anti-BCMA CAR T cells (CXCR4 modified anti-BCMA CAR T cells)

Multiple Myeloma · BCMA

#BCMA#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 ACTIVE
AntibodystaleJanssenPhase 2

daratumumab (Darzalex, KRd, Carfilzomib, lenalidomide, dexamethasone, Carfilzomib, lenalidomide, dexamethasone (KRd) + Daratumumab)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
CGTBiologicstaleO&D BioTech Group CO., LimitedPhase 1

Chimeric antigen receptor T cell O&D-001 injection targeting BCMA and GPRC5D (Chimeric antigen receptor T cell O&D-001 injection targeting BCMA and GPRC5D)

Relapsed or Refractory Multiple Myeloma · BCMA

#BCMA#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING
ADCBiologicstaleMultiple Myeloma Research Conso…Phase 2

Cobimetinib, dexamethasone, ixazomib, pomalidomide (Cobimetinib, dexamethasone, ixazomib, pomalidomide)

Relapsed Refractory Multiple Myeloma · FRα

#FR#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 ACTIVE
AntibodystaleJanssenPhase 3

daratumumab (Darzalex, Cyclo Thal Dex Daratumumab)

Multiple Myeloma Stage I · Multiple Myeloma Stage I

#MultipleMyelomaStageI#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleJanssenPhase 2

Part 2 (Daratumumab, Daratumumab (Part 2))

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleJanssenPhase 1

daratumumab (Darzalex, Daratumumab Hyaluronidase-fihj)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleJanssenPhase 3

daratumumab (Darzalex, Daratumumab Only Product in Parenteral Dose Form)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleJanssenPhase 2

daratumumab (Darzalex, Daratumumab plus Velcade Cyclophosphamide Dexamethasone)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleJanssenPhase 2

daratumumab (Darzalex, Daratumumab with dexamethasone)

Relapsed/Refractory Multiple Myeloma · FRα

#FR#Antibody#Phase2#항체#면역항체+4
효능 ORR 18.4%임상시험 1상태 ACTIVE
AntibodystaleJanssenPhase 2

daratumumab (Darzalex, Daratumumab, Ixazomib, Dexamethasone)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleJanssenPhase 3

daratumumab (Darzalex, Daratumumab/Lenalidomide/Dexamethasone for 24 months)

Multiple Myeloma in Relapse · Multiple Myeloma in Relapse

#MultipleMyelomainRelapse#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleJanssenPhase 3

daratumumab (Darzalex, Daratumumab/Lenalidomide/Dexamethasone until progression)

Multiple Myeloma in Relapse · Multiple Myeloma in Relapse

#MultipleMyelomainRelapse#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleJanssenPhase 2

daratumumab (Darzalex, Daratumumab/rHuPH20 Co-formulation)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleJanssenPhase 3

Daratumumab (Darzalex Faspro, Darzalex Faspro(Daratumumab))

Refractory or Relapsed Multiple Myeloma · FRα

#FR#Antibody#Phase3#항체#면역항체+3
임상시험 1상태 RECRUITING
ADCBiologicstaleMedImmune LLCPhase 1

antibody drug conjugate (Dose Escalation, MEDI2228, ADC, Dose Escalation, MEDI2228, ADC (antibody drug conjugate))

Relapsed/Refractory Multiple Myeloma · FRα

#FR#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3
임상시험 1상태 ACTIVE
ADCBiologicstaleMedImmune LLCPhase 1

antibody drug conjugate (Dose Expansion, MEDI2228, ADC, Dose Expansion, MEDI2228, ADC (antibody drug conjugate))

Relapsed/Refractory Multiple Myeloma · FRα

#FR#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3
임상시험 1상태 ACTIVE
CGTBiologicstaleBeijing GoBroad HospitalPhase 1

Dual-targeting BCMA-CD19 CAR-T cell infusion (Dual-targeting BCMA-CD19 CAR-T cell infusion)

Relapsed or Refractory Multiple Myeloma (RRMM) · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING
CGTBiologicstaleMemorial Sloan Kettering Cancer…Phase 1

EGFRt/BCMA-41BBz CAR T cell (EGFRt/BCMA-41BBz CAR T cell)

Multiple Myeloma · EGFR

#EGFR#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING
CGTBiologicstaleUniversity of ArkansasPhase 2

ENK Cell Infusion (ENK Cell Infusion)

Asymptomatic Multiple Myeloma · Asymptomatic Multiple Myeloma

#AsymptomaticMultipleMyeloma#CGT#Phase2#세포유전치료#CAR-T+2
임상시험 1상태 ACTIVE

7 / 11 페이지

← 이전다음 →